Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Intercell AG

Headquarters: Vienna, Austria
Website: N/A
Year Founded: 1997
Status: Merged

BioCentury | Oct 8, 2021
Management Tracks

Doyle joins Aro as CMO

Plus: CytoDyn, HealthCap, MinervaX, Oculis and more
BioCentury | Aug 10, 2015
Company News

Intercell, Novartis deal

BioCentury | Nov 20, 2014
Strategy

Mixing it up at Karolinska

BioCentury | Apr 14, 2014
Clinical News

IC43: Phase II/III ongoing

BioCentury | Mar 3, 2014
Company News

Valneva, Sanofi deal

BioCentury | Nov 18, 2013
Clinical News

AERAS-456: Phase I/IIa started

BioCentury | Nov 4, 2013
Clinical News

IC43: Phase II/III halted

BioCentury | Nov 1, 2013
Clinical News

Valneva falls on IC43 vaccine trial update

BioCentury | Oct 7, 2013
Clinical News

C: Phase Ib data

BioCentury | Jul 29, 2013
Clinical News

Ixiaro regulatory update

Items per page:
1 - 10 of 270